baber/WOPTO huggingface dataset:
Patent NZ-537831-A (NZ)
Title: Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
Inventor: BUSACCA CARL A
IPC: C07D471/04
Filed: 2003-06-20
Abstract: Disclosed is a process for making a compound of formula (I) as defined in the specification wherein: R2 is selected from the group consisting of H, F, Cl, alkyl, cycloalkyl and CF3; R4 is H or Me; R5 is H, Me or Et; R11 is Me, Et, cyclopropyl, propyl, isopropyl or cyclobutyl; and Q is as defined in the specification. Said process comprises: reacting a compound of formula (II) with a malonate as defined in the specification to yield an intermediate of formula (IV); hydrolyzing The intermediate of formula (IV) to form an intermediate of formula (V) as defined in the specification; reducing the carboxylic acid or ester intermediate of formula (V) to form the alcohol of formula (VI) as defined in the specification; and condensed the alcohol of formula (VI) with reactants as defined to form the product of formula (I). Also disclosed are the intermediates (IV) and (V) and processes of forming them.
Patent NZ-540750-A (NZ)
Title: Sets of oligonucleotide probes for diagnosis
Inventor: SHARMA PRAVEEN
IPC: G16B25/20
Filed: 2003-11-21
Abstract: Disclosed is a set of oligonucleotide probes, for use in assessing gene transcript levels in a cell, which may be used in analytical techniques, particularly diagnostic techniques and kits containing the same.
Patent NZ-544732-A (NZ)
Title: Face mask hood sealing and retaining system and method
Inventor: SCHULTZ TRENT M
IPC: A62B18/08
Filed: 2004-04-16
Abstract: A face mask retaining system is disclosed. The face mask retaining system comprises a face mask (14), a hood (12) configured as a head cover, a mounting band (16) integral with the hood (12), a head harness (18) and at least one bracket (20). These five parts work together to secure the mask to the face of the user. The hood (12) is configured to couple to the face mask (14) and form a seal between the hood (12) and the face mask (14). The head harness (18) is configured to hold the face mask (14) against the face of a user and comprises a plurality of flanges (70) configured to extend around the hood (12). It also has a plurality of orifices (72) within each of the flanges (70) configured to couple to the coupling structures (30) of the integral mounting band (16) and the coupling structure (50) of the at least one bracket (20). The at least one bracket (20) is configured to couple the face mask (14) to the integral mounting band (16), the integral mounting band (16) comprising a plurality of spaced apart coupling structures (30) configured to couple to the head harness (18) to the at least one bracket (20).
Patent NZ-544773-A (NZ)
Title: Cysteine-rich secretory protein (CRISP) trypsin inhibitor polypeptides and polynucleotides
Inventor: AGARWAL PANKAJ
Filed: 2001-09-13
Abstract: An isolated polypeptide selected from the group consisting of: (a) an isolated polypeptide encoded by a polynucleotide comprising the sequence SEQ ID NO:24 set forth in Table I; and (b) an isolated polypeptide comprising the polypeptide sequence SEQ ID NO: 68 set forth in Table I. Also described is an isolated polynucleotide selected from the group consisting of: (a) an isolated polynucleotide comprising the polynucleotide sequence SEQ ID NO:24 set forth in Table I; (b) an isolated polynucleotide comprising a polynucleotide sequence encoding the polypeptide SEQ ID NO:68 set forth in Table I; (c) an isolated polynucleotide encoding the polypeptide SEQ ID NO:68 set forth in Table I; (d) a polynucleotide which is an RNA equivalent of the polynucleotide of (a) to (c); or a polynucleotide sequence complementary to said isolated polynucleotide; an expression vector comprising a polynucleotide capable of producing the polypeptide; and a process for producing a recombinant host cell which comprises the step of introducing an expression vector comprising a polynucleotide capable of producing the polypeptide into a cell.
Patent NZ-554295-A (NZ)
Title: Portable apparatus for analysis of a refinery feedstock or a product of a refinery process
Inventor: GUDDE NICHOLAS JOHN
IPC: G01N25/08
Filed: 2005-09-15
Abstract: A portable apparatus for measuring the boiling point profile, density and total acid number of a refinery feedstock or a product of a refinery process is disclosed. The measurement is used in generating a determinative assay of the refinery feedstock or the product of a refinery process. The apparatus includes: (a) a first portable microfabricated analyticai device for determination of a boiling point profile of the refinery feedstock or the product of a refinery process, and (b) at least two further portable microfabricated analytical devices each of which contains or is employed in conjunction with a database and an algorithm. At least one of the further devices is adapted for determination of the density of the refinery feedstock or the product of a refinery process. At least one of the further devices is adapted for determination of the total acid number of the refinery feedstock or the product of a refinery process. The measured boiling point profile, density and total acid number are input to the database and algorithm to generate a determinative assay of the refinery feedstock or product of a refinery process.
Patent NZ-554801-A (NZ)
Title: Method and apparatus for oil shale pollutant sorption/nox reburning multi-pollutant control
Inventor: BOARDMAN RICHARD D
IPC: F23C99/00
Filed: 2005-11-21
Abstract: A method of decreasing the pollutants produced by the combustion of a primary fuel (coal) by introducing into the combustion chamber 6 oil shale particles when the pollutants produced include at least at least one pollutant selected from a first group consisting of a nitrogen-containing pollutant, sulphuric acid, sulphur trioxide, carbonyl sulphide, carbon disulfide, chlorine, hydroiodic acid, iodine, hydrofluoric acid, fluorine, hydrobromic acid, bromine, phosphoric acid, phosphorous pentoxide and a second group consisting of elemental mercury or mercuric chloride. The oil shale particles combust to produce sorbent particulates and a reductant. Pollutants from the first group are exposed to at least one of the sorbent particulates and the reductant at a temperature ranging from greater than or equal to approximately 450°C to less than approximately 1150°C. Pollutants from the second group are exposed to sorbent particles at a temperature of less than or equal to approximately 200°C.
Patent NZ-556253-A (NZ)
Title: Object tracking method and apparatus
Inventor: COATES MICHAEL JOHN
IPC: B64F1/36
Filed: 2007-06-29
Abstract: A method of tracking objects within an object transportation system comprises a) providing an object identification code for an object; b) capturing visual identification information for the object at a first location within the system; c) relating the visual identification information captured at the first location with the object identification code; d) capturing visual identification information at a second location within the system; e) comparing the visual identification information captured at the second location to the visual identification information captured at the first location; and f) relating the visual identification information captured at the second location to the object identification code if the visual identification information captured at the first and second locations meet predefined comparison criteria. A baggage tracking apparatus comprises a conveyer to convey the object; a first camera (16a) to capture visual identification information for the object at a first location of the conveyer; a second camera (16b) to capture visual identification information for the object at a second location of the conveyer; a scanner (21) to provide an object identification code for the object; and a computer server adapted to carry out the above described method of tracking objects.
Patent NZ-562411-A (NZ)
Title: Nasal pillow mask assembly
Inventor: GUNARATNAM MICHAEL KASSIPILLAI
IPC: A61M16/08
Filed: 2004-02-20
Abstract: A nasal pillows mask assembly for providing a supply of air at positive pressure to the entrance of a patient's airways includes a nasal pillows assembly defining a chamber 52 comprising a pair of nasal pillows 18 including a first portion 56 of reduced cross-section connected at a first end to a base portion and structured to allow for relative movement with respect to the base portion, and to be pre-loaded against the patient's nostril and a second portion connected to a second end of the first portion, the second portion 50 having a narrower first end that enters the nasal passage of the patient's nose in use and a wider second end, the second portion defining a surface 58 upon at least a portion of which sealing occurs with a patient's nares on the underside of the nostrils in an area about the rim of the nostril openings in use and a base portion 54 constructed of a deformable, resilient and flexible material including sidewalls having a generally thicker end 48 adapted for connection to a frame and decreasing in thickness to a thinner central portion, the sidewalls being arranged to act as a spring structure to provide a component of force on the patient's face through the nasal pillows. The nasal pillows assembly is connected to a frame and a headgear assembly is connected to the frame and structured to retain the frame in position on the face of a patient. An air delivery conduit is adapted to receive a supply of air at positive pressure and direct it to the chamber.
Patent NZ-569113-A (NZ)
Title: Device for changing stopper and method for changing stopper
Inventor: YAHAGI KEIICHI
IPC: B67D1/04
Filed: 2003-05-23
Abstract: A device for extracting a bottle stopper of a bottle that contains fluid, particularly wine, is disclosed. The device (151) includes an airtight container (153) detachably mountable on a head of the bottle via an airtight mounting mouth (155), a corkscrew (163) contained in the airtight container together with a substitute stopper (167), and an operation body (165) capable of operating the corkscrew with one hand of a user from outside said airtight container while holding the bottle with the other hand. At least a part of the airtight container is made of a deformable member, the deformable member including a deformable bag attached to the mounting mouth. The substitute stopper is able to be mounted on the head of the bottle after the bottle stopper (C) is detached. Operation of the corkscrew and manipulation of the substitute stopper are carried out from an outside of the airtight container by using a flexibility of the deformable member. The container may have a valve for a supply of deterioration preventive gas (157), and an outlet valve (159) for discharging air.
Patent NZ-572193-A (NZ)
Title: Nasolacrimal drainage system implants for drug therapy with non-fluid swellable retention structure around drug core
Inventor: DE JUAN EUGENE
IPC: A61K31/215
Filed: 2007-04-02
Abstract: Implant 100 has drug core 110 typically surrounded by sheath 120 which is in turn typically surrounded by an expandable body 140 which is non-fluid swellable, so as to be able to retain the implant in a canalicular lumen and allow release of the drug material to the eye. Various other embodiments are disclosed.
Patent NZ-573217-A (NZ)
Title: A facility for conversion of carbonaceous feedstock into a reformulated syngas containing CO and H2
Inventor: TSANGARIS ANDREAS
IPC: C10J1/207
Filed: 2007-05-05
Abstract: A low-temperature gasification system with a horizontally oriented gasifier is disclosed that optimizes the extraction of gaseous molecules from carbonaceous feedstock while minimizing waste heat. The system comprises a plurality of integrated subsystems that work together to convert municipal solid waste (MSW) into electricity. The subsystems comprised by the low-temperature gasification system are: a Municipal Solid Waste Handling System; a Plastics Handling System; a Horizontally Oriented Gasifier with Lateral Transfer Units System; a Gas Reformulating System; a Heat Recycling System; a Gas Conditioning System; a Residue Conditioning System; a Gas Homogenization System and a Control System. The gasifier itself has a gasification chamber with one or more feedstock inputs, one or more gas outputs and a solid residue output; a chamber heating system, two or more substantially laterally distributed processing zones and one or more lateral transfer units for laterally transferring reactant material through the processing zones during processing. This sequentially promotes drying, volatilization, char-to-ash conversion. The gas reformulating system has a gas reformulating chamber, one or more plasma heat torches and one or more inputs for oxygen sources. In the gas reformulating system conversion of the off-gas into a reformulated syngas containing CO and H2 takes place. The residue conditioning system contains a source of plasma heat for converting the residue from the gasifier into molten slag. The facility as a whole is controlled by a feedback control system. A method for converting carbonaceous feedstock into syngas comprising CO and H2, and slag is also disclosed.
Patent NZ-577007-A (NZ)
Title: Improvements in and relating to drive mechanisms suitable for use in drug delivery devices
Inventor: BOYD MALCOM
IPC: A61M5/30
Filed: 2007-11-08
Abstract: Provided is drive mechanism for use in a drug delivery device is provided comprising: a housing having a proximal and a distal end; a drive member located within the housing such that the drive member is movable longitudinally and is non-rotatable with respect to the housing; a piston rod that is non-rotatable with respect to the housing and is adapted to operate through the housing and transfer a force in the longitudinal direction to the distal end of the drug delivery device; a rotating means releasably engaged with the piston rod and engaged to the drive member and engaged to the housing wherein the rotating means is selected from the group of (i) to (iii), (i) a carrier plate having pawl arms and a gear, (ii) a carrier plate having pawl arms and a lever, (iii) a lever assembly; characterized in that, a) when the drive member moves proximally with respect to the housing the rotating means moves proximally with respect to the piston rod; b) when the drive member moves distally the rotating means moves distally displacing the piston rod towards the distal end of the device.
Patent NZ-580710-A (NZ)
Title: Diagnosis of melanoma by nucleic acid analysis
Inventor: CHANG SHERMAN H
IPC: C12Q1/6886
Filed: 2008-05-02
Abstract: A method of diagnosing melanoma in a subject by detecting the expression of tetratricopeptide repeat domain 3 alone or in combination with one or more of Hyptothetical protein MGC40222, tribbles homolog 2 (Drosophilia), endothelin receptor type B, ribosomal protein S15, c-Maf-inducing protein and myosin heavy polypeptide 14. The method can also distinguish melanoma from dysplastic nevi or normal pigmented skin
Patent NZ-587484-A (NZ)
Title: Method of producing a thermized unripened cheese and cheese obtained
Inventor: FURLING OLIVIER
IPC: A23C19/097
Filed: 2009-02-24
Abstract: Disclosed is a method of producing a cheese, according to which an intermediate cheese body is prepared, the intermediate cheese body comprising; - a drained cheese curd, or - a cheese curd reconstituted by mixing and hydrating animal or vegetable protein and fat concentrates; - a first treatment at a temperature of from 40 to 90°C is carried out on the cheese body; - a texturizing treatment is carried out at the temperature of the first treatment in order to obtain a textured body; - the textured body is subjected to a second heat treatment by ohmic heating at a temperature of from 90 to 140°C for from 10 seconds to 5 minutes; - the body obtained is cooled to a temperature below 100°C in order to obtain a cheese; and - the cheese is packaged.
Patent NZ-601141-A (NZ)
Title: Nutritional formulas containing synbiotics
Inventor: THOMAS DEBRA L
IPC: C12R1/225
Filed: 2011-01-18
Abstract: Disclosed is a composition for treating or preventing allergic disease, comprising: - a carbohydrate, a lipid component, and a protein; - a probiotic comprising Lactobacillus rhamnosus HN001; and - a prebiotic selected from the group consisting of fructooligosaccharides, galactooligosaccharides, synthetic human milk oligosaccharides, and combinations thereof, wherein the composition comprises, as a percentage of total calories, 10% to 70% carbohydrate, 5% to 50% lipid component, and 10% to 80% protein, and wherein the composition is an infant formula. Also disclosed is the use of said composition in the manufacture of a medicament for treating or preventing allergic disease.
Patent NZ-601598-A (NZ)
Title: Can body
Inventor: RILEY JONATHAN
IPC: B21D22/20
Filed: 2011-02-04
Abstract: A drawn and ironed tinplate can body adapted for seaming onto a can end, the can body comprising: - an ironed sidewall (2) - an enclosed, undomed base (1) integrally formed with the sidewall, a bottom panel of the base having an average Rockwell 30T hardness number that is at least approximately 64. Additionally the base is characterised as having either (i) a Rockwell hardness number that is at least approximately 65 or (ii) an average change in hardness from the raw sheet of at least 5 in Rockwell hardness number or (iii) or an average change in Rockwell hardness number from the raw sheet of at least 7%. The can bottom can also be described as having an average thickness between 0.006 and 0.015 inches, the bottom panel having an average decrease in thickness from the raw sheet of at least 2%. A further characteristic of the can bottom could be grains in the base tin plate having an average aspect ratio of at least 1.4.
Patent NZ-610983-A (NZ)
Title: Neprilysin inhibitors
Inventor: GENDRON ROLAND
IPC: C07D271/06
Filed: 2011-12-14
Abstract: Provided are gamma-(biphenyl-4-ylmethyl)-gamma-amino-butyric acid derivative compounds of general formula (I) wherein X is a C1-9 heteroaryl and the other variables are as defined in the specification. Examples of the compounds include (2R, 4S)-5-biphenyl-4-yl-2-hydroxy-4-[(3-hydroxy-isoxazole-5-carbonyl)-amino]-5-methyl-hexanoic acid and (2S, 4S)-2-hydroxy-4-[(3-hydroxy-3H-benzotriazole-5-carbonyl)-amino]-5-(3 ‘-methyl-biphenyl-4-yl)-pentanoic acid. Further provided are processes and intermediates for the preparation of the compounds, pharmaceutical compositions comprising the compounds, and methods of treatment using the compounds. The compounds are inhibitors of neprilysin (neutral endopeptidase). The compounds are useful for the treatment of hypertension and heart failure.
Patent NZ-612262-A (NZ)
Title: Development of very early flowering and normal fruiting plum with fertile seeds
Inventor: SRINIVASAN CHINNATHAMBI
IPC: C12N15/82
Filed: 2010-12-03
Abstract: A method of making an early and continually flowering transgenic Prunus (plum tree) plant exhibiting an early and continually flowering phenotype, said method including: a) transforming a regenerable tissue of a Prunus plant with a recombinant construct having a Populus trichocarpa Flowering Locus T1 (PtFT1) cDNA and one or more regulatory elements operatively linked to the cDNA wherein the PtFT1 cDNA encodes the polypeptide of SEQ ID NO: 2 or with a vector having the recombinant construct; b) culturing the transformed Prunus plant regenerable tissue in vitro; c) regenerating transgenic Prunus plantlets from the transformed Prunus plant regenerable tissue; d) rooting the transgenic Prunus plantlets; e) acclimating the rooted transgenic Prunus plantlets in a growth chamber; f) planting the acclimated transgenic Prunus plantlets in a temperature controlled greenhouse; g) selecting for a growing transgenic Prunus plant having the recombinant construct and exhibiting an early and continuing flowering phenotype h) pollinating transgenic Prunus flowers on the growing transgenic Prunus plant with pollen from compatible Prunus cultivars; and i) selecting for a growing transgenic Prunus plant having the recombinant construct and exhibiting an early and continually flowering phenotype and producing ripe fruit with fertile seeds.
Patent NZ-616855-A (NZ)
Title: Intelligent table gaming system
Inventor: KRISHNAMURTY VENKATA
IPC: A63F1/14
Filed: 2011-11-08
Abstract: Disclosed is a system for monitoring the playing cards in play during a card game. The system comprises a plurality of playing cards (100). Each playing card (100) includes a region of interest (110) on which micro-dots (120) are printed in a pattern. The pattern encodes the rank and suit of the card (100), where the micro-dots (120) are not visible to the naked human eye. The invention also discloses a shoe for holding the playing cards (100) and method for detecting micro-dots (120) on the card (100).
Patent NZ-623987-A (NZ)
Title: Document processing and notating method and system
Inventor: GLASSOP LINDA
IPC: G06Q50/10
Filed: 2012-11-12
Abstract: Disclosed is a method of creating a structured word processing document that is arranged in a specific format. The method comprising the steps of opening the document to be processed in one of a plurality of view types; creating one or more composition frames (C-frames). Each of the C-frame (402, 404, 406) containing data inserted by a user and selected by the user based on the use of the C-frame (402, 404, 406) within the structured document. The one or more C-frames (402, 404, 406) is then displayed on a screen to enable editing or ordering of each C-frame (402, 404, 406) to compose the structured document; and a style guide from a database of predefined style guides is selected. Each style guide defining formatting styles to be consistently applied to particular types or instances of C-frames (402, 404, 406) within the structured document. The selected style guide is applied for formating the structured document to a predefined format.
Patent NZ-628189-A (NZ)
Title: Therapeutic nuclease compositions and methods
Inventor: LEDBETTER JEFFREY A
IPC: C12N9/22
Filed: 2010-11-02
Abstract: Disclosed is a polypeptide comprising human RNase 1 operatively coupled with or without a first linker domain to an Fc domain, wherein the Fc domain is a mutant human IgG1 Fc domain with reduced binding to Fcγ receptors on human cells, and wherein the mutant human IgG1 Fc domain does not comprise a whole antibody.